Address: Beijing's xizhimen south street, xicheng district
The British garden 1 floor. Room 824
Zip code: 100035
Telephone: 010-58562339
Fax: 010-58562339
Email address: cngjzj@163.com
Web site (click on the url link directly left) :
http://www.cngjzj.com/
Blog (click on the url link directly left) :
http://blog.sina.com.Cn/CNGJZJ
To xizhimen south street, xicheng district building to the British garden route
L airport line 1
Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.
L airport line 2
From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.
L bus subway near:
106 bus GuanYuan: 107 road, express way
Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road
Che zhuang: subway line two
Xizhimen subway: metro line 2
Buses and attempts: 107 road, 118 road, 701 road
Buses and north zhuang: 209 road, 375 road, 392 road
2016年04月14日
复制链接
打印
大 中 小
Tu double hydrogen artemisinin cure lupus erythematosus (sle) approved clinical trial
Time: 2016-04-14
Source: China's traditional Chinese medicine
Author: Zhao Weiting
Report from our correspondent (reporter Zhao Weiting) tu researcher is responsible for the "double hydrogen artesunate treatment of lupus erythematosus (sle)" research recently by the state food and drug supervision and management of the administration of examination and approval, the approval documents for drug clinical trials.
Lupus erythematosus (sle) is a kind of hard to cure autoimmune disease in which patients up to hundreds of millions of people in our country, the clinical chronic lack of new treatments. This kind of drug development is the international YaoXueJie widely regarded as one of the most challenging research field.
Tu team after decades of research, found that the double hydrogen immunomodulatory effects of artemisinin, efficacy and clinical curative effect is distinct, and preliminary experiments confirmed the lupus erythematosus (sle) and in accordance with the "drug registration management approach", completed the double hydrogen artemisinin for the treatment of lupus erythematosus (sle) application for preclinical studies and clinical trials. By the Beijing municipal food and drug administration and the state food and drug administration of management review, in conformity with the relevant provisions of the drug registration, agreed to double hydrogen artemisinin clinical trials for the treatment of lupus erythematosus (sle).
Your position is：
